[Form 4] Home Bancorp, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Natalie B. Lemoine, SEVP and Chief Administrative Officer of Home Bancorp, Inc. (HBCP), reported an open-market purchase of 1,000 shares of the issuer's common stock on 08/20/2025 at $26.81 per share, increasing her direct holdings to 6,314 shares. The filing also reports indirect ownership of 1,451.073 shares held via an ESOP. The Form 4 lists multiple outstanding employee stock options and restricted stock unit grants: several options covering 400–500 shares each and one 1,000-share option, with exercise prices ranging from $21.99 to $45.12 and various vesting schedules; restricted stock units totaling multiple grants that vest in 20% annual installments beginning on specified dates. The report is limited to changes in beneficial ownership and security awards and does not include company financial results.

Positive

• Insider purchase documented: Reporting person acquired 1,000 shares at $26.81 on 08/20/2025, increasing direct ownership to 6,314 shares.
• Transparency in awards: Filing provides detailed schedules for multiple RSU grants and option vesting dates, clarifying future dilution/timing.

Negative

• Outstanding dilution potential: Multiple unvested RSUs and employee stock options remain outstanding, which could dilute existing shareholders when settled.
• No materiality context: The filing does not provide company financial metrics, so the economic significance of the purchase relative to total holdings or company market cap is not shown.

Insights

Financial Analyst

TL;DR: Insider purchased 1,000 HBCP shares at $26.81 and holds both direct and ESOP-linked indirect positions; multiple outstanding options and RSUs remain.

The reported buy is a modest open-market purchase that raises direct ownership to 6,314 shares and confirms 1,451.073 shares held indirectly in an ESOP. The filing details numerous employee stock options with exercise prices from $21.99 to $45.12 and scheduled vesting, plus multiple RSU grants that vest 20% annually. For investors, this filing documents insider accumulation and the executive's compensation mix of equity and deferred awards; the amounts are disclosed but not large relative to typical institutional holdings. No financial performance data or material corporate actions are included.

Corporate Governance Expert

TL;DR: The Form 4 discloses routine insider purchase and standard equity compensation vesting schedules—no governance red flags shown.

The reporting person is an officer and director, and the Form 4 transparently lists both direct purchases and the structure of outstanding equity awards, including RSUs and options with multi-year vesting. Vesting commencement dates and remaining unvested RSUs are specified for several grants, which is consistent with retention-style executive compensation. The filing contains required signatures and explanations; it does not disclose any departures, policy changes, or unusual transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lemoine Natalie B.

(Last) (First) (Middle)

503 KALISTE SALOOM ROAD

(Street)

LAFAYETTE LA 70508

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HOME BANCORP, INC. [ HBCP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SEVP, Chief Admin. Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/20/2025		M		1,000	A	$26.81	6,314	D(1)(2)(3)(4)(5)
Common Stock								1,451.073	I	ESOP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$28							(6)	05/23/2026	Common Stock	500		500	D
Employee Stock Option (Right to Buy)	$35.26							(7)	05/12/2027	Common Stock	400		400	D
Employee Stock Option (Right to Buy)	$45.12							(8)	05/23/2028	Common Stock	500		500	D
Employee Stock Option (Right to Buy)	$35.85							(9)	05/23/2029	Common Stock	500		500	D
Employee Stock Option (Right to Buy)	$36.77							(10)	05/12/2031	Common Stock	500		500	D
Employee Stock Option (Right to Buy)	$21.99							(11)	03/12/2030	Common Stock	500		500	D
Employee Stock Option (Right to Buy)	$26.81	08/20/2025		M			1,000	(12)	01/12/2026	Common Stock	1,000	$0	0	D

Explanation of Responses:

1. Includes the grant of 1250 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2025, and that may be settled only in shares of the Issuer's common stock.

2. Includes the grant of 250 restricted stock units pursuant to the Issuer's 2014 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2022, and that may be settled only in shares of the Issuer's common stock. As of July 15, 2024, 100 restricted stock units remain unvested.

3. Includes the grant of 750 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2023, and that may be settled only in shares of the Issuer's common stock. As of July 15, 2024, 450 restricted stock units remain unvested.

4. Includes the grant of 800 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2024, and that may be settled only in shares of the Issuer's common stock. As of July 15, 2024, 640 restricted stock units remain unvested.

5. Includes the grant of 1391 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2026, and that may be settled only in shares of the Issuer's common stock.

6. The options vest and become exercisable in five equal installments beginning May 23, 2017

7. The options vest and become exercisable in five equal installments beginning May 12, 2018.

8. The options vest and become exercisable in five equal installments beginning May 23, 2019.

9. The options vest and become exercisable in five equal installments beginning May 23, 2020

10. The options vest and become exercisable in five equal installments beginning May 12, 2022.

11. The options vest and become exercisable in five equal installments beginning March 12, 2021.

12. The options vest and become exercisable in five equal installments beginning January 12, 2017

	/s/ Natalie B. Lemoine	08/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Natalie B. Lemoine report on Form 4 for HBCP?

The Form 4 reports an open-market purchase of 1,000 shares of Home Bancorp, Inc. common stock on 08/20/2025 at a price of $26.81 per share.

How many HBCP shares does Natalie B. Lemoine beneficially own after the reported transaction?

Following the reported transaction she beneficially owns 6,314 shares (direct) and has 1,451.073 shares (indirect via ESOP).

What equity awards are disclosed in the Form 4 for HBCP?

The filing lists multiple employee stock options (underlying amounts of 400–1,000 shares) with exercise prices from $21.99 to $45.12, and several restricted stock unit grants that vest in 20% annual installments beginning on specified dates.

Are there any exercised options or option settlements reported in this Form 4?

The form shows an option-related transaction code 'M' for 1,000 option shares at an exercise price of $26.81 dated 08/20/2025, but the filing lists the derivative holdings and vesting schedules rather than a cash exercise resulting in new reported direct shares beyond the 1,000 purchased.

Does the Form 4 indicate any change in the reporting person's role at HBCP?

No. The filing identifies Natalie B. Lemoine as a Director and SEVP, Chief Administrative Officer; it does not report any role changes.